Cowen Prime Advisors’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $305K | Hold |
7,000
| – | – | 0.1% | 72 |
|
|
2023
Q1 | $305K | Hold |
7,000
| – | – | 0.12% | 72 |
|
|
2022
Q4 | $261K | Hold |
7,000
| – | – | 0.11% | 75 |
|
|
2022
Q3 | $279K | Hold |
7,000
| – | – | 0.16% | 61 |
|
|
2022
Q2 | $268K | Hold |
7,000
| – | – | 0.15% | 66 |
|
|
2022
Q1 | $278K | Hold |
7,000
| – | – | 0.12% | 76 |
|
|
2021
Q4 | $291K | Hold |
7,000
| – | – | 0.1% | 72 |
|
|
2021
Q3 | $295K | Hold |
7,000
| – | – | 0.11% | 70 |
|
|
2021
Q2 | $321K | Hold |
7,000
| – | – | 0.12% | 65 |
|
|
2021
Q1 | $328K | Hold |
7,000
| – | – | 0.12% | 65 |
|
|
2020
Q4 | $299K | Sell |
7,000
-7,000
| -50% | -$359K | 0.13% | 61 |
|
|
2020
Q3 | $689K | Buy |
14,000
+7,000
| +100% | +$387K | 0.34% | 47 |
|
|
2020
Q2 | $268K | Sell |
7,000
-7,000
| -50% | -$370K | 0.15% | 66 |
|
|
2020
Q1 | $637K | Hold |
14,000
| – | – | 0.39% | 48 |
|
|
2019
Q4 | $923K | Hold |
14,000
| – | – | 0.42% | 42 |
|
|
2019
Q3 | $809K | Hold |
14,000
| – | – | 0.42% | 41 |
|
|
2019
Q2 | $806K | Sell |
14,000
-2,200
| -14% | -$102K | 0.39% | 46 |
|
|
2019
Q1 | $625K | Hold |
16,200
| – | – | 0.32% | 50 |
|
|
2018
Q4 | $618K | Hold |
16,200
| – | – | 0.37% | 53 |
|
|
2018
Q3 | $625K | Hold |
16,200
| – | – | 0.29% | 59 |
|
|
2018
Q2 | $606K | Hold |
16,200
| – | – | 0.3% | 58 |
|
|
2018
Q1 | $474K | Hold |
16,200
| – | – | 0.26% | 60 |
|
|
2017
Q4 | $604K | Hold |
16,200
| – | – | 0.29% | 60 |
|
|
2017
Q3 | $611K | Hold |
16,200
| – | – | 0.29% | 54 |
|
|
2017
Q2 | $436K | Hold |
16,200
| – | – | 0.2% | 61 |
|
|
2017
Q1 | $319K | Hold |
16,200
| – | – | 0.16% | 62 |
|
|
2016
Q4 | $308K | Hold |
16,200
| – | – | 0.17% | 68 |
|
|
2016
Q3 | $264K | Hold |
16,200
| – | – | 0.12% | 97 |
|
|
2016
Q2 | $222K | Hold |
16,200
| – | – | 0.11% | 88 |
|
|
2016
Q1 | $252K | Hold |
16,200
| – | – | 0.12% | 86 |
|
|
2015
Q4 | $260K | Hold |
16,200
| – | – | 0.11% | 84 |
|
|
2015
Q3 | $193K | Hold |
16,200
| – | – | 0.09% | 103 |
|
|
2015
Q2 | $230K | Hold |
16,200
| – | – | 0.09% | 97 |
|
|
2015
Q1 | $233K | Hold |
16,200
| – | – | 0.1% | 104 |
|
|
2014
Q4 | $227K | Hold |
16,200
| – | – | 0.09% | 108 |
|
|
2014
Q3 | $211K | Hold |
16,200
| – | – | 0.09% | 106 |
|
|
2014
Q2 | $227K | Hold |
16,200
| – | – | 0.09% | 92 |
|
|
2014
Q1 | $269K | Hold |
16,200
| – | – | 0.1% | 83 |
|
|
2013
Q4 | $305K | Hold |
16,200
| – | – | 0.12% | 82 |
|
|
2013
Q3 | $305K | Hold |
16,200
| – | – | 0.12% | 90 |
|
|
2013
Q2 | $278K | Buy |
+16,200
| New | +$259K | 0.12% | 91 |
|
Other funds holding NRC
CCA
QI
Cowen Prime Advisors's NRC Position: Q2 2023 in Review
Cowen Prime Advisors held its NRC Health Common Stock (NRC) position steady in Q2 2023 at 7,000 shares worth $305K. The position accounts for 0.1% of the portfolio, ranked #72.
Cowen Prime Advisors first reported a position in NRC in Q2 2013 and has held it in 41 quarters since. The position peaked at $923K in Q4 2019. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.
- Cowen Prime Advisors held 7,000 shares of NRC Health Common Stock worth $305K as of Q2 2023.
- Cowen Prime Advisors left its NRC Health Common Stock share count unchanged in Q2 2023.
- NRC Health Common Stock made up 0.1% of Cowen Prime Advisors's portfolio in Q2 2023, its #72 holding.
- Cowen Prime Advisors first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's NRC Health Common Stock position peaked at $923K in Q4 2019.
- 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.